SCA
ABBV icon

Sandy Cove Advisors’s AbbVie ABBV Stock Holding History

Sandy Cove Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$438K Buy
1,740
+39
+2% +$8.39K 0.11% 97
2026
Q1 		$370K Buy
1,701
+19
+1% +$4.21K 0.11% 97
2025
Q4 		$384K Buy
1,682
+108
+7% +$24.6K 0.11% 99
2025
Q3 		$364K Sell
1,574
-31
-2% -$6.31K 0.12% 100
2025
Q2 		$298K Sell
1,605
-274
-15% -$50.9K 0.11% 99
2025
Q1 		$394K Buy
1,879
+287
+18% +$55.8K 0.16% 79
2024
Q4 		$283K Buy
1,592
+187
+13% +$34.4K 0.11% 104
2024
Q3 		$277K Buy
1,405
+111
+9% +$20.7K 0.11% 101
2024
Q2 		$222K Sell
1,294
-47
-4% -$7.79K 0.1% 105
2024
Q1 		$244K Buy
+1,341
New +$231K 0.11% 110
2023
Q4 		– Sell
-3,221
Closed -$480K – 121
2023
Q3 		$480K Buy
3,221
+12
+0.4% +$1.76K 0.28% 59
2023
Q2 		$432K Buy
3,209
+1,223
+62% +$179K 0.25% 69
2023
Q1 		$317K Sell
1,986
-10
-0.5% -$1.53K 0.23% 68
2022
Q4 		$323K Buy
1,996
+275
+16% +$42.2K 0.26% 58
2022
Q3 		$231K Hold
1,721
– – 0.21% 63
2022
Q2 		$264K Hold
1,721
– – 0.24% 57
2022
Q1 		$279K Hold
1,721
– – 0.23% 59
2021
Q4 		$233K Buy
+1,721
New +$203K 0.2% 68

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Sandy Cove Advisors's ABBV Position: Q2 2026 in Review

Sandy Cove Advisors increased its AbbVie (ABBV) stake by 2.3% in Q2 2026, buying an estimated $8.39K and bringing the position to 1,740 shares worth $438K. The position accounts for 0.11% of the portfolio, ranked #97.

Sandy Cove Advisors first reported a position in ABBV in Q4 2021 and has held it in 18 quarters since. The position peaked at $480K in Q3 2023. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Sandy Cove Advisors held 1,740 shares of AbbVie worth $438K as of Q2 2026.
  • Sandy Cove Advisors bought 39 AbbVie shares in Q2 2026, an estimated $8.39K.
  • AbbVie made up 0.11% of Sandy Cove Advisors's portfolio in Q2 2026, its #97 holding.
  • Sandy Cove Advisors first reported a position in AbbVie in Q4 2021 and has held it in 18 quarters since.
  • Sandy Cove Advisors's AbbVie position peaked at $480K in Q3 2023.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Sandy Cove Advisors's 13F filing for Q2 2026, filed 7 Jul 2026.